Pharmaceutical industry: hazardous waste generation, treatment, and disposal
The studies were conducted for information purposes only and not in response to a Congressional regulatory mandate. As such, the studies serve to provide EPA with: (1) an initial data base concerning current and projected types and quantities of industrial wastes and applicable disposal methods and costs; (2) a data base for technical assistance activities; and (3) a background for guidelines development work pursuant to Sec. 209, Solid Waste Disposal Act, as amended. The study had four basic objectives: To determine the nature and quantities of hazardous wastes originating from the pharmaceutical industry (1973) and to project these wastes to 1977 and 1983; To determine the current treatment and disposal practices within the industry; To examine improved control technologies which could be applied to reduce hazards presented by the wastes; and, To calculate the cost of implementing control technology in a typical hypothetical or existing plant. (GRA)
- Research Organization:
- Environmental Protection Agency, Research Triangle Park, NC (USA)
- OSTI ID:
- 7223335
- Report Number(s):
- PB-258800; EPA/SW-508
- Country of Publication:
- United States
- Language:
- English
Similar Records
Water Pollution Control Act of 1972, regional impacts, San Francisco Bay/Central Valley. Final report
Characterization of treatment residues from hazardous-waste treatment, storage, and disposal facilities
Related Subjects
320305* -- Energy Conservation
Consumption
& Utilization-- Industrial & Agricultural Processes-- Industrial Waste Management
COST
DRUGS
ENVIRONMENTAL PROTECTION AGENCY
HAZARDOUS MATERIALS
INDUSTRIAL WASTES
MANAGEMENT
WASTE DISPOSAL
WASTE MANAGEMENT
WASTES